News Releases

Printer friendly version

Protox grants stock options

Wednesday, September 15, 2004 - Vancouver, British Columbia- Protox Therapeutics Inc. ("Protox") Board of Directors today announced that they have granted 970,000 options pursuant to its previously approved stock option plan. The options were granted to directors, officers, key employees and consultants to the Company.

The exercise price of the options is $1.00 per share, vesting 25% one year from the date of the grant and the remaining 75% in equal increments on a monthly basis over the following three years. These options expire July 13, 2009.

For more information contact:

Terry Vanderkruyk
Director, Investor Relations
Protox Therapeutics Inc.
604-688-4376 tel
604-789-0844 cell
604-688-0173 fax
tvanderkruyk@protoxtherapeutics.com